Abstract

Background: Scabies is a common parasitic skin infestation transmitted mainly through direct skin contact. Permethrin was considered the standard treatment; however, due to increasing resistance against permethrin, recent research investigates the eff ect of other topical preparations like ivermectin as an alternative treatment. Aim of the study: This study aim to evaluate the effi cacy and safety of ivermectin whether its topical alone or combined with oral form of ivermectin in the same time on scabietic lesions compared to permethrin. Patient and method: 236 patients with uncomplicated scabies participated in the study. The study population was selected and divided randomly into three groups. The fi rst group received permethrin, the second group received topical ivermectin, and the third group received a combination of topical and oral ivermectin. Each patient received two doses one week apart. The patients were followed up for the fi rst, second, and fourth week of treatment. Results: At the fi rst week, the group who received the combination of treatments has a signifi cant decrease in both severity of itching and number of lesions, the reduction percentage is (77.6, 53.9%), respectively compared to (61.8, 55.2%) with topical ivermectin and ( 8.3, 19% ) with permethrin. At the 4th week, 15.8% of patients in the combination treatment group reported severe itching, signifi cantly lower than the corresponding values in the other groups. Conclusion: The combination of topical and oral ivermectin is safe and more eff ective than topical ivermectin or permethrin alone. It achieves a remarkable eff ect in the fi rst week.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.